Skip to main content
. 2020 Nov 16;21(22):8619. doi: 10.3390/ijms21228619

Figure 5.

Figure 5

(A) Relative Pparg transcript levels in the visceral white adipose tissue (WAT) of WT (n = 4) and SCD2KO (n = 6) mice fed HFD for 10 weeks. (B) Relative Pparg transcript levels in differentiated primary preadipocytes from WT (n = 3) and SCD2KO (n = 3) mice. (C) Relative Pparg transcript levels in the brown adipose tissue (BAT) of WT (n = 3) and SCD2KO (n = 4) mice fed HFD for 10 weeks. (D) Immunoblot analysis of PPARγ in visceral WAT of WT (n = 2) and SCD2KO (n = 2) mice fed HFD for 10 weeks. (E) Relative lipogenic gene expression in WT (n = 3), SCD1KO (n = 3), and SCD2KO (n = 3) primary preadipocytes treated with MDI, rosiglitazone (R), and indomethacin (I). Values are mean ± SEM, * p < 0.05 vs. WT, ** p < 0.01 vs. WT, *** p < 0.005 vs. WT by Student′s two-tailed t-test. Dots represent individual values.